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Alzheimer’s disease (AD)1 is one of a number of diseases in
which proteins form amyloid aggregates. The brains of patients
with AD contain large numbers of amyloid deposits in the form
of senile plaques (1). The amyloid core of these plaques contains
interwoven fibrils that are composed of 40- and 42-residue
peptides (2, 3), denoted A␤-(1– 40) and A␤-(1– 42). These peptides are produced by cleavage of cellular amyloid precursor
protein by two proteases called ␤- and ␥-secretase (reviewed in
Ref. 4). As originally suggested by the amyloid cascade hypothesis (5), it appears likely that A␤ aggregates are important in
the etiology of AD. The most striking evidence supporting this
hypothesis comes from the identification of numerous mutations linked to early onset familial AD (6). These mutations are
located within the amyloid precursor protein gene or the genes
for presenilins 1 and 2, which play an integral role in ␥-secretase activity. All early onset familial AD mutations reported
thus far increase either the level of the more amyloidogenic
A␤-(1– 42) peptide (reviewed in Ref. 6) or the propensity of a
mutated A␤ to form amyloid aggregates (7). Whereas early
evidence suggested that A␤ fibrils initiate a cascade of events
that result in neuronal cell death (8), a number of investigators
now propose that soluble aggregates of A␤ (also called oligomers or protofibrils), rather than monomers or insoluble
amyloid fibrils, may be responsible for synaptic dysfunction in
AD (9 –13). This proposal is supported by observations that
soluble aggregates generated in vitro from synthetic A␤-(1– 40)
and -(1– 42) induced toxicity in cultured cells (10, 14), that
soluble A␤ aggregates produced in cell culture markedly inhibited hippocampal long term potentiation in rats in vivo (15),
and that transgenic mice expressing human A␤ show functional deficits that precede extracellular deposition of fibrillar
A␤ (12, 16).
Amyloid fibrils from a number of proteins share certain
structural features. They contain fully extended peptide segments that align to form ␤-sheets with the extended peptide
strands perpendicular to and interstrand hydrogen bonds parallel to the fibril axis (17, 18). This cross-␤ structure may
underlie common properties including the binding of dyes like
thioflavin T and Congo Red and of antibodies that react with a
common epitope in several amyloidogenic proteins (19, 20).
However, recent reports also indicate a fascinating degree of
amyloid polymorphism at the molecular level. This feature was
first noted with mammalian and yeast prion proteins when it
was shown that a single polypeptide can misfold into multiple
amyloid conformations (21). Specifically, the yeast Sup35p
1
The abbreviations used are: AD, Alzheimer’s disease; AFM, atomic
force microscopy; BSA, bovine serum albumin; DLS, dynamic light
scattering; EM, electron microscopy; HFIP, hexafluoroisopropanol;
MALS, multiangle light scattering; SEC, size exclusion chromatography; TFE, trifluoroethanol; GM1, monosialogangliotetraosylceramide.
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The brains of Alzheimer’s disease (AD) patients contain
large numbers of amyloid plaques that are rich in fibrils
composed of 40- and 42-residue amyloid-␤ (A␤) peptides.
Several lines of evidence indicate that fibrillar A␤ and
especially soluble A␤ aggregates are important in the etiology of AD. Recent reports also stress that amyloid aggregates are polymorphic and that a single polypeptide
can fold into multiple amyloid conformations. Here we
demonstrate that A␤-(1– 40) can form soluble aggregates
with predominant ␤-structures that differ in stability and
morphology. One class of aggregates involved soluble A␤
protofibrils, prepared by vigorous overnight agitation of
monomeric A␤-(1– 40) at low ionic strength. Dilution of
these aggregation reactions induced disaggregation to
monomers as measured by size exclusion chromatography. Protofibril concentrations monitored by thioflavin T
fluorescence decreased in at least two kinetic phases,
with initial disaggregation (rate constant ⬃1 hⴚ1) followed by a much slower secondary phase. Incubation of
the reactions without agitation resulted in less disaggregation at slower rates, indicating that the protofibrils
became progressively more stable over time. In fact, protofibrils isolated by size exclusion chromatography were
completely stable and gave no disaggregation. A second
class of soluble A␤ aggregates was generated rapidly (<10
min) in buffered 2% hexafluoroisopropanol (HFIP). These
aggregates showed increased thioflavin T fluorescence
and were rich in ␤-structure by circular dichroism. Electron microscopy and atomic force microscopy revealed
initial globular clusters that progressed over several days
to soluble fibrous aggregates. When diluted out of HFIP,
these aggregates initially were very unstable and disaggregated completely within 2 min. However, their stability increased as they progressed to fibers. Relative to A␤
protofibrils, the HFIP-induced aggregates seeded elongation by A␤ monomer deposition very poorly. The techniques used to distinguish these two classes of soluble A␤
aggregates may be useful in characterizing A␤ aggregates
formed in vivo.
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several orders of magnitude faster than those observed in
buffer alone. These HFIP aggregates, like the A␤ aggregates
formed at the chloroform-buffer interface, gave CD spectra rich
in ␤-structure, formed globular species that progressed to fibers based on EM and AFM images, and initially disaggregated
rapidly on dilution. We propose that these features provide
useful criteria for investigating the polymorphism of soluble A␤
aggregates.
EXPERIMENTAL PROCEDURES

Materials—A␤-(1– 40) and A␤-(1– 42) peptides were obtained from
QCB (Hopkinton, MA), from rPeptide (Athens, GA), and from the protein and peptide core facility at the Mayo Clinic (Rochester, MN).
[3H]HCHO was from PerkinElmer Life Sciences and ARC (St. Louis,
MO); scintillation mixture (Ultima Gold) was from PerkinElmer Life
Sciences; and HFIP, EDTA, bovine serum albumin, and thioflavin T
were from Sigma. HFIP stocks were redistilled prior to experimental
use.
Preparation of A␤ Monomers—A␤-(1– 40) peptide was obtained in
lyophilized form and stored at ⫺20 °C, desiccated until reconstitution,
either in 0.1 M Tris-HCl, pH 8, at 3– 4 mg/ml (460 –930 M) or in
deionized water (18 megaohms; Millipore Milli-Q system) at 2.5 mg/ml
(580 mM). Aliquots of the water stocks were flash frozen in ethanol/dry
ice, stored at ⫺80 °C, and thawed at room temperature when needed.
Any preformed aggregates were removed from stock solutions by SEC
on Superdex 75, and concentrations of A␤ (shown under “Results” to be
monomeric) were determined by absorbance with a calculated extinction coefficient of 1450 cm⫺1 M⫺1 at 276 nm as previously described (35).
In some experiments, A␤ peptides were radiolabeled by reductive methylation of primary and secondary amino groups (46) as described previously (35). [3H]HCHO was used directly (98 mCi/mmol; PerkinElmer
Life Sciences) or after dilution (10 Ci/mmol; ARC) with unlabeled
HCHO. The reaction converted the ⑀-amino groups of two lysine residues (Lys16 and Lys28) and the ␣-amino group of the N-terminal residue
(Asp1) to labeled dimethylamines (35), with specific activities of 400 –
1100 dpm/pmol of A␤.
Preparation of A␤ Protofibrils—SEC-purified monomeric A␤-(1– 40)
(100 –140 M) was incubated in 0.5–1 ml of 5–50 mM Tris-HCl, 5 mM
EDTA (sodium salt), pH 8.0 (5–50 mM Tris-EDTA), at room temperature and agitated vigorously by continued vortexing to promote aggregation (35). Aggregation was monitored by thioflavin T fluorescence (35,
51), and the sample was microcentrifuged for 10 min in a tabletop
centrifuge (Beckman Coulter) at 18,000 ⫻ g. The supernatant was
chromatographed on a 1 ⫻ 30-cm Superdex 75 HR 10/30 column (Amersham Biosciences), and A␤ eluting in the void volume was defined as
the protofibril fraction (35). Superdex columns were routinely pretreated with a bolus of BSA (50 mg) in running buffer to block nonspecific binding of A␤ protofibrils to the resin followed by a wash with at
least 4 column volumes of running buffer. The columns also were
occasionally washed with 1 N NaOH.
Circular Dichroism—Spectra were obtained on an Aviv model 215
circular dichroism spectrometer with a 0.1-cm path length quartz cuvette (Hellma) (41). Buffer control spectra were averaged and subtracted from the average of triplicate scans of each A␤ sample spectra,
and each resulting point ([]obs, degrees) was converted to mean residue
ellipticity ([], degrees cm2 dmol⫺1) with the equation, [] ⫽ []obs⫻
(MRW/10lc), where MRW is the mean residue molecular weight of
A␤-(1– 40) (4331 g/mol divided by 40 residues), l is the optical path
length (cm), and c is the concentration (g/cm3). Estimates of the predominant secondary structure were verified using the modified Contin
method (CONTINLL) available through the CDPro suite of analysis
programs with basis set 7 of the reference protein data base (47).
Dynamic Light Scattering (DLS)—Hydrodynamic radius (RH) measurements were made at room temperature with a DynaPro MSX instrument (Protein Solutions Inc., Piscataway, NJ) equipped with a gallium
aluminum arsenide laser. Samples (60 l) were placed directly into a
quartz cuvette, and total light scattering intensity at a 90° angle in
kilocounts/s was collected using a 5-s acquisition time. Particle translational diffusion coefficients (DT) were calculated from autocorrelated
light intensity data (usually 20 –25 points) and converted to RH with the
Stokes-Einstein equation (RH ⫽ kbT/6DT). A histogram of percentage
intensity versus RH was calculated using Dynamics data analysis software (Protein Solutions), and intensity-weighted mean RH values were
obtained for each subpeak.
Multiangle Light Scattering (MALS)—Samples were applied to a
Superdex 75 SEC column attached to an ÄKTA fast protein liquid
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prion protein was aggregated at different temperatures into
amyloid conformations that could be distinguished by thermal
stability and EPR spectroscopy, and infection of yeast with
these different conformations led to different propagating yeast
[PSIⴙ] strains (22, 23). A␤ fibrils also show molecular diversity.
Solid state NMR measurements revealed that A␤-(1– 40), A␤(1– 42), and A␤-(10 –35) fibrils contained in-register, parallel
␤-sheets (24, 25), whereas fibrils formed by the shorter peptides A␤-(16 –22), A␤-(34 – 42), and A␤-(11–25) adopted antiparallel ␤-strand alignments (26 –28). Very recently, two types of
amyloid fibrils were formed by A␤-(1– 40) following aggregation
under mildly agitated or quiescent conditions, and chemical
shift and line width data from solid-state NMR for 33 of the 40
residues indicated different underlying structures (29).2
Amyloid polymorphism is closely linked to the mechanism of
A␤ fibrilformation,whichinvitroisthoughttoinvolvenucleationdependent polymerization (31, 32). In this process, monomeric
A␤ associates noncovalently to form nuclei or “seeds,” which
then grow into soluble protofibrils and insoluble fibrils. Nucleus formation is considered rate-limiting in this process, but
this rate is highly variable even in homogeneous aqueous solutions and is sensitive to many conditions including pH, ionic
strength, temperature, and agitation (33–35). If different nuclear structures form, the molecular structure of fibrils formed
by polymerization will vary with the structure of the nucleus.
One measure of this conformational specificity is the efficiency
with which aggregates can “cross-seed,” or act as seeds for
elongation by another or even the same amyloidogenic polypeptide (36). Nucleation in vivo may be promoted by interfaces,
including phospholipid membranes. Anionic phospholipid vesicles (37) as well as vesicles containing GM1 ganglioside (38 –
40) promoted A␤ binding and ␤-structure formation in vitro.
The emergence of amyloid polymorphism underscores the
need for measures that would distinguish amyloid aggregates
formed under different conditions. One measure that has received little attention is aggregate stability. In this report, we
document the stability of A␤-(1– 40) protofibrils prepared in
dilute buffer at neutral pH (35) by measuring their disaggregation rates following dilution. Isolated protofibrils became
progressively more stable over time and reached a point where
no disaggregation could be detected. This stability contrasted
with that of A␤ aggregates generated at interfaces. We recently
observed that A␤-(1– 40) aggregates formed rapidly at the interface of an aqueous solution over chloroform were relatively
unstable, and their morphology differed significantly from that
of A␤-(1– 40) protofibrils (41). Here we extend this characterization to A␤-(1– 40) aggregates formed in dilute hexafluoroisopropanol (HFIP). High concentrations of the fluorinated alcohols trifluoroethanol (TFE) and HFIP have been popular
agents for solubilizing peptides and proteins (42). The ability of
these agents to induce ␣-helical conformations is well known,
but they also promote other types of intramolecular hydrogen
bonding including turns and ␤-hairpins (42). In solutions that
contain more than 50% TFE, A␤ (43) and the amyloidogenic
protein ␣-synuclein (44) showed largely ␣-helical conformations, but in 20% TFE, both formed ␤-sheet aggregates at rates
that were considerably faster than those in the absence of TFE.
Padrick and Miranker (45) recently reported that low concentrations of HFIP (1– 4%) dramatically promoted amyloid fiber
formation by islet amyloid polypeptide, and their observations
encouraged us to examine A␤ in dilute HFIP. We found that
A␤-(1– 40) also aggregated in dilute HFIP with rates that were
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chromatography system and analyzed in-line with a DAWN EOS MALS
instrument (Wyatt Technology, Santa Barbara, CA) (35). Analysis of
MALS data was based on the Zimm formalism of the Rayleigh-DebyeGans model (48, 49), as presented previously (35). In brief, the excess
Rayleigh ratio R is related to the molecular structure according to
Equation 1,
Kc
1
⫹ 2A 2c
⫽
R  MP共  兲

(Eq. 1)

where R is proportional to the fraction of incident light that is scattered
by the solute without interference; K is a physical constant equal to
42(dn/dc)2no2NA⫺1o⫺4, where n represents the refractive index of the
solution, c is the solute concentration (g/ml), no is the refractive index of
the solvent, NA is Avagadro’s number, and o is the wavelength of the
incident light in vacuum; A2 is the second virial coefficient; and M is the
molecular mass of the solute. At the low concentrations c employed in
this study, the 2A2c term in Equation 1 may be ignored. The function
P() is the ratio of the scattered light intensity to the scattered light
intensity without interference. For larger molecules whose size approaches o, the reciprocal P⫺1() may be expressed by the power series
in Equation 2,
P ⫺1共  兲 ⫽ 1 ⫹

q 2R g2
⫹...
3

(Eq. 2)

RESULTS

Dissociation of A␤ Aggregates—Aggregates were prepared
from unlabeled or radiomethylated A␤-(1– 40) monomer that
had been purified by SEC (35). Radiomethylation of A␤-(1– 40)
converts the primary amino groups on residues Asp1, Lys16,
and Lys28 to radiolabeled dimethylamines. This modification
slows the assembly kinetics but does not affect the morphology
of protofibrils or fibrils (35), and it significantly enhances the
detection of A␤. The monomeric nature of low molecular weight
A␤ obtained from SEC was confirmed by multiangle light scattering in tandem with SEC. This analysis was conducted with
radiomethylated A␤ for better quantitation and indicated a Mw
of 4670 ⫾ 90 (calculated MW 4415 for the hexamethylated 1– 40
peptide). The monomeric assignment was in agreement with
translational diffusion measurements by NMR (50).

FIG. 1. A␤-(1– 40) aggregates measured by thioflavin T fluorescence become more stable over time. SEC-purified monomers of
3
[ H]A␤-(1– 40) (140 M) in 50 mM Tris-EDTA (A) and unlabeled A␤-(1–
40) (100 M) in 5 mM Tris-EDTA (B) were incubated with agitation for
22 h and maintained at room temperature without further manipulation. At the indicated times (in days), an aliquot was diluted 30-fold (A)
or 40-fold (B) into 5 mM Tris-EDTA buffer containing 5 M thioflavin T.
The fluorescence (F) was fit to a five-parameter double exponential
curve (F ⫽ F0 ⫹ ae⫺bt ⫹ ce⫺dt) with SigmaPlot 8.0, where F0 is the initial
fluorescence, t is time, and b and d are fluorescence decay rate constants for fast and slow kinetic phases with amplitudes represented by
a and c.

Monomeric A␤-(1– 40) was aggregated at low ionic strength
with agitation as outlined previously (35), conditions that produced predominantly soluble protofibrils that could not be sedimented by centrifugation at 18,000 ⫻ g. After overnight aggregation, the reactions were incubated for various times before
removing aliquots for large dilutions, which were necessary to
minimize further monomer deposition and reveal disaggregation. The time course of disaggregation was conveniently monitored with thioflavin T, a fluorophore that shows greatly
enhanced fluorescence on binding to amyloid fibrils (51). 30 –
40-fold dilution of A␤-(1– 40) aggregation reactions into buffer
containing thioflavin T initiated a progressive decrease in fluorescence (Fig. 1). This decrease reflected disaggregation of the
A␤ protofibrils, since it was accompanied by a decrease in DLS
intensity and by an increase in the percentage of A␤ monomer
as measured by SEC (see below). The fluorescence decrease
occurred in at least two kinetic phases, with rapid initial disaggregation followed by a much slower secondary phase. For
the earliest dilutions, the disaggregation rate constants for the
rapid phase were 15 h⫺1 for the radiomethylated A␤-(1– 40)
protofibrils (Fig. 1A) and 1 h⫺1 for the unlabeled protofibrils
(Fig. 1B), indicating that the radiomethylated protofibrils were
less stable than the unlabeled protofibrils. However, the most
striking observation with both aggregation reactions was the
progressive stabilization of the A␤ protofibrils, as demonstrated by decreased disaggregation rate constants and increased percentages of stable protofibrils after dilution at longer incubation times. For example, the percentage of initial
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where q ⫽ (4no/o)sin(/2),  is the angle between the incident and the
scattered light, and Rg is the root mean square radius of gyration.
According to Equations 1 and 2, a Zimm plot of Kc/R as a polynomial in
q2 gives (M)⫺1 as the y axis intercept and Rg2/3M as the limiting slope
as  approaches zero. When the solute is polydisperse, M and Rg become
the weight-average molecular mass (Mw) and the z-average radius of
gyration (Rgz), respectively. For very small molecules, P() is equal to 1,
and little slope is observed in the Kc/R versus q2 plot. This precludes
Rgz determination but still allows Mw measurements if the concentration is known. Definitive concentration measurements from radioactivity allowed Mw determination of radiomethylated, monomeric
A␤-(1– 40).
Electron Microscopy (EM)—Samples of A␤ aggregates were applied
to 200-mesh Formvar-coated copper grids (Ernest F. Fullam, Inc.,
Latham, NY) and incubated for 10 –15 min at room temperature. The
sample was then wicked off with lens paper, washed briefly by placing
the grid face down on a wash droplet, and stained by transferring the
grid face down to a droplet of 2% uranyl acetate (Polysciences, Inc.,
Warrington, PA) for 5–10 min before wicking off the solution and air
drying. With samples generated in 2% HFIP, all wash and treatment
solutions applied to the grids also contained 2% HFIP. Grids were
visualized in a Philips EM208S transmission electron microscope.
Atomic Force Microscopy (AFM)—Images were obtained as described
previously (35). In brief, samples were applied to freshly cleaved mica
that had been modified with 3⬘-aminopropyl-triethoxysilane and incubated for 15 min. The residual sample liquid was aspirated off, and the
disk was then rinsed gently with water containing 2% HFIP and blown
dry with compressed air. A Nanoscope III controller with a Multimode
AFM (Digital Instruments, Santa Barbara, CA) was used for imaging
by ambient tapping mode. Images here are presented in amplitude
mode, where increasing brightness indicates greater damping of cantilever oscillation (34). Height mode images were “flattened” prior to the
measurement of particle height distributions with NanoScope® III software (version 5.13r5; Digital Instruments).
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FIG. 3. Isolated [3H]A␤-(1– 40) protofibrils become more stable
over time. [3H]A␤-(1– 40) protofibrils (12 M), isolated by SEC in 5 mM
Tris-EDTA, were incubated at room temperature for 1 month without
further manipulation. Aliquots were diluted 16-fold into the same
buffer at the indicated times, and protofibril content was measured by
thioflavin T fluorescence as in Fig. 1.

fluorescence retained after disaggregation of the radiolabeled
A␤ sample increased from 37% after dilution on the first day to
80% at 50 days (Fig. 1A).
To verify that the decrease in thioflavin T fluorescence in
Fig. 1 corresponded to dissociation of A␤ monomers from protofibrils, the aggregation reactions before and after dilution
were analyzed by SEC. However, analysis of the predilution
radiomethylated protofibrils was complicated by apparent oncolumn dissociation during the SEC separation itself. This
dissociation is illustrated by comparison of the radioactivity
elution profiles for the pre- and postdilution 18-day samples in
Fig. 2A. The predilution profile displayed radioactivity between
the completely excluded protofibril peak (8 –10 ml) and the
monomer peak (13–15 ml). Experiments with larger samples
have shown that the A␤ species in this region do not induce
thioflavin T fluorescence, suggesting that they are monomers
resulting from protofibril dissociation during the chromatography run rather than small oligomers (data not shown). Furthermore, this region of radioactivity vanished, and the monomer peak increased in the postdilution sample, clearly
indicating that monomer dissociation had occurred. Quantitative comparison of the extent of dissociation with the fluorescence decrease in Fig. 1A was easier with the sample after
stabilization during 42 days of incubation. SEC analysis
showed that this sample, which produced much less radiolabel
between the protofibril and monomer peaks (Fig. 2B), contained 32% monomer prior to dilution and 50% monomer 15 h
after dilution. This 18% increase was in excellent agreement
with the slow 20% decrease in fluorescence over this time
period.
The shift in the compositions of the A␤ aggregation mixtures
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FIG. 2. SEC analyses of an [3H]A␤-(1– 40) aggregation reaction
confirm monomer dissociation following dilution. The aggregation reaction in Fig. 1A was incubated for 18 (A) and 42 days (B) and
then fractionated by SEC in 5 mM Tris-EDTA. Samples were applied
before (●, solid line) and 15 h after (E, dotted line) the dilution described in the legend to Fig. 1. Protofibril (7.5–12.5 ml) and monomer
(13–17 ml) peaks were quantified by scintillation counting of collected
fractions.

in Figs. 1 and 2 with increasing time of incubation reflected
both continued monomer deposition and progressive stabilization of the protofibrils. Protofibrils prior to dilution of the
radiomethylated sample in Fig. 1A increased from an initial
32% of total radiolabel to 68% after incubation for 42 days. One
simple explanation for the stabilization is that smaller, less
stable protofibrils rapidly disaggregate and disappear, whereas
larger, more stable protofibrils continue to grow. However, size
analysis of the samples in this experiment by DLS and MALS
revealed little change in the RH, Rgz, and Mw of the protofibrils
during the 50-day incubation. Postdissociation protofibrils remaining after dilution had slightly larger Rgz values than the
predilution protofibrils, suggesting that the loss of smaller, less
stable A␤ aggregates makes a slight contribution to the overall
stabilization.
Dissociation of Isolated A␤ Protofibrils—An unequivocal
demonstration of the progressive stabilization of A␤ protofibrils was obscured in Figs. 1 and 2 by the presence of a significant concentration of A␤ monomer at all time points prior to
dilution (for the [3H]A␤-(1– 40), at least 40 M). Continued
deposition of monomer could simply have elongated the protofibrils without increasing the number of ends from which dissociation might occur, and this process would contribute to the
apparent stabilization in Fig. 1. To eliminate this continued
deposition from our analysis, we isolated freshly aggregated A␤
protofibrils by SEC prior to studying their dissociation on dilution. Some rapid monomer dissociation occurred during the
isolation (see Fig. 2A), and considerable variability in stability
was observed among different isolated protofibril preparations.
Unlabeled A␤-(1– 40) protofibrils were more stable than radiomethylated A␤-(1– 40) protofibrils, as observed previously
with the aggregation mixtures in Fig. 1, but even some radiomethylated protofibril preparations were extremely stable
and did not show discernible monomer dissociation on dilution
(data not shown). A less stable pool of isolated radiomethylated
protofibrils was incubated at room temperature without perturbation, and aliquots were diluted into solutions with thioflavin T at various time points (Fig. 3). Fluorescence decreases
again occurred in at least two kinetic phases, although the
disaggregation rate constants for the initial phase were slower
than those in Fig. 1 because some rapidly disaggregating species were lost during protofibril isolation. Significantly, a progressive time-dependent stabilization of the protofibrils was
observed even in the absence of monomer (Fig. 3). Disaggregation rate constants decreased, and higher percentages of stable
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protofibrils remained after dilution as the protofibrils aged.
Here the increase in protofibril stability was accompanied by a
gradual increase in average protofibril RH from 50 nm immediately after isolation to 98 nm after 26 days. We have shown
previously that this increase in average RH in the absence of
monomer results from association of protofibrils to form larger
protofibrils and fibrils (35). Mechanisms contributing to the
progressive stabilization of isolated protofibrils in the absence
of monomer deposition remain to be identified but may include
protofibril association.
Dilute HFIP Promotes Rapid Formation of Unstable A␤ Aggregates—The data we have presented so far indicate that
A␤-(1– 40) protofibrils become progressively more stable with
continued incubation. We now show that A␤ aggregates are
formed rapidly in dilute HFIP, and these aggregates exhibit a
dramatically broader range of stability. HFIP is widely known
as an effective solvent for A␤ peptides (52). A␤-(1– 40) protofibrils and fibrils were solubilized at HFIP concentrations above
20% (v/v), as indicated by loss of thioflavin T fluorescence and
conversion to monomeric A␤ on SEC (data not shown). However, low concentrations of HFIP were striking in their ability
to promote A␤ aggregation. The time scale for nonagitated
aggregation of A␤-(1– 40) was reduced from weeks to minutes
over a narrow range of HFIP concentrations from 1 to 2% (v/v)
(see Fig. 4A), and the usual lag time for A␤ aggregation (35, 53)
was abolished. Most of the A␤ appeared to aggregate in 2%
HFIP, since the maximum thioflavin T fluorescence per M
total A␤ was comparable for the protofibrils in Fig. 1 and the
HFIP-induced aggregates in Fig. 4A. However, slightly less
aggregation was observed at 4% HFIP, and none was observed
at 10% HFIP. The aggregation did not require a particular
mixing sequence, since similar rates were observed when stock
A␤ in 50% HFIP was diluted or a small volume of neat HFIP
was added to diluted A␤ (data not shown). The HFIP induced
aggregates were soluble, since virtually no fluorescence was
removed from the supernatant after centrifugation of the reactions in Fig. 4A at 18,000 ⫻ g for 10 min. Although radiomethylation slows the aggregation of A␤-(1– 40) (35) and A␤(1– 42) (data not shown) by roughly an order of magnitude in
our routine A␤ aggregation procedure (as defined in Fig. 1),
this effect is lost in 2% HFIP, since unlabeled and radiomethylated A␤-(1– 40) aggregated at similar rates (Fig. 4B). A␤-(1–
42) in vitro is more prone to aggregation into protofibrils and
fibrils than A␤-(1– 40) (31, 32), and this difference is retained in
2% HFIP even after radiomethylation of A␤-(1– 42) (Fig. 4B).
Dilution of HFIP into aqueous buffers gives a dispersion with
modest DLS intensity, probably resulting from the formation of
a polydisperse population of HFIP microdroplets, discussed
with Fig. 7, below. These microdroplets represented only a tiny
fraction of the dissolved HFIP, since most of the HFIP particles
responsible for the light scattering intensity were removed by
centrifugation at 18,000 ⫻ g for 10 min with less than a 5%
decrease in the supernatant HFIP concentration as measured
by 19F NMR (data not shown). However, the rate of A␤-(1– 40)
aggregation was significantly slowed in these HFIP supernatants relative to that in the initial HFIP dispersion (Fig. 4C).
Ultracentrifugation of the HFIP supernatant at 100,000 ⫻ g for
1 h had no further effect on either light scattering intensity or
the A␤-(1– 40) aggregation rate. The light scattering components initially in dilute HFIP also could be eliminated simply
by storing the solution for several days, and this storage (or
“aging”) also was sufficient to slow the A␤-(1– 40) aggregation
rate (Fig. 4C).
The A␤ aggregates formed in dilute HFIP appeared to possess significant ␤-structure based on their fluorescence with
thioflavin T. This structure was confirmed by CD analysis
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FIG. 4. Low concentrations of HFIP dramatically accelerate
the aggregation of A␤ peptides. A, undiluted HFIP was added to the
indicated final percentages (v/v) to solutions containing SEC-purified
monomeric A␤-(1– 40) (20 M) and 5 M thioflavin T in 30 mM Tris-HCl
(pH 8.0), and continuous fluorescence measurements were initiated
immediately. B, the aggregations of SEC-purified unlabeled and radiomethylated A␤ monomers (10 M) in 5 mM Tris-EDTA containing 2%
HFIP. C, a 4% HFIP solution in water (pre-spin) was centrifuged at
18,000 ⫻ g for 10 min (post-spin) or sealed and stored for 8 days (aged).
Light scattering intensity by DLS decreased from 428 kilocounts/s
before to 17 kilocounts/s after centrifugation. Aliquots were mixed with
an equal volume of SEC-purified monomeric [3H]A␤-(1– 40) (20 M) in
60 mM Tris-EDTA.

below. Therefore, it was surprising that the aggregates initially
were very unstable when diluted into buffer and thioflavin T
without HFIP (Fig. 5A). 15-fold dilution of the aggregates
formed after 30 min in 2% HFIP resulted in a fluorescence
decrease so fast that actual measurement was precluded. In
contrast, maintenance of the HFIP at 2% in the dilution buffer
significantly slowed the fluorescence decrease (Fig. 5A). It appears that HFIP at low concentrations is a significant stabilizing agent for A␤ aggregates that were initially formed in dilute
HFIP.
Prolonged incubation of A␤-(1– 40) in dilute HFIP resulted in
a marked stabilization of the aggregates without an increase in
the overall thioflavin T binding (Fig. 5B). Disaggregation rate
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constants on dilution into buffer without HFIP were decreased
and, after nearly 10 days, approached the rate constant obtained for disaggregation of A␤ protofibrils formed in the absence of HFIP. The HFIP-induced aggregates remained soluble
despite this stabilization. In only one case, after incubation in
2% HFIP for several days at a higher buffer concentration (30
mM Tris-HCl), were the aggregates sedimented at 18,000 ⫻ g
for 10 min. Although similar initial disaggregation rates were
observed for radiomethylated and unlabeled A␤-(1– 40) aggregates produced in 2% HFIP, the radiolabeled aggregates
showed much less stabilization over time.
Both A␤ Protofibrils and HFIP-induced A␤ Aggregates Are
Rich in ␤-Structure—Previous analyses of CD spectra for 39 –
42-residue A␤ peptides prior to aggregation have concluded
that the conformations are largely random coil in aqueous
buffers (37, 54) and predominantly ␣-helical in acidic (55) and
neutral (56) pH solutions that contain ⱖ20% HFIP. Our spectra in Fig. 6A are consistent with these conclusions, as indicated by the presence of a single minimum at 197 nm for stock
monomeric A␤-(1– 40) in buffer and double minima at 208 and
222 nm for the stock A␤-(1– 40) in buffer with 30% HFIP. In
contrast, A␤-(1– 40) protofibrils isolated by SEC exhibit a min-

imum at 216 nm and a maximum at 195 nm (Fig. 6A), indicating a preponderance of ␤-structure (sheet and turn) as reported
previously for A␤-(1– 40) fibrils (57) and protofibrils (58) generated in vitro. The addition of monomeric A␤-(1– 40) to fresh
2% HFIP gave a rapid increase in thioflavin T fluorescence in
Fig. 4A, suggesting formation of an amyloid aggregate rich in
␤-structure, and this was supported by the minimum at 216 nm
in the CD spectra in Fig. 6B. The addition of monomeric A␤(1– 40) to 2% HFIP that had been centrifuged to remove apparent HFIP aggregates gave a smaller increase in thioflavin T
fluorescence in Fig. 4C, and this correlated with a smaller shift
at 216 nm in the corresponding CD spectrum in Fig. 6B. Inclusion of the random coil spectrum for control monomeric A␤-(1–
40) in Fig. 6B revealed an isodichroic point at 209 nm for these
three solutions, indicating a two-component mixture with varying amounts of the component rich in ␤-structure. Given the
instability of this component on dilution in Fig. 5A, we infer
that the mixture involved a rapid equilibrium between the
random coil and ␤-structures. Our data are consistent with a
previous report that A␤-(1– 40) formed ␤-structure at HFIP
concentrations of 3–10% (56).
HFIP-induced A␤ Aggregates Initially Are Globular but Progress to Fibers—DLS and MALS are effective tools for structural analysis of large but still soluble particles, and both have
been used previously to characterize A␤ protofibrils (32, 35).
Like protofibrils, the HFIP-induced A␤ aggregates generally
were soluble following centrifugation at 18,000 ⫻ g for 10 min.
RH values obtained by DLS for the initial A␤ aggregates in-
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FIG. 5. A␤-(1– 40) aggregates induced by dilute HFIP initially
are very unstable but stabilize over time. A, SEC-purified monomeric A␤-(1– 40) (20 M) was incubated without agitation in 5 mM
Tris-EDTA containing 5 M thioflavin T and 2% (v/v) HFIP for 30 min
at room temperature. A rapid increase in fluorescence similar to that in
Fig. 4 was observed. Disaggregation was then initiated by diluting the
mixture 15-fold into the same buffer with thioflavin T with or without
2% HFIP, and the decrease in fluorescence was monitored. B, conditions
were identical to those in A except that the 2% HFIP aggregation was
buffered with 50 mM Tris-EDTA and A␤-(1– 40) was 60 M, and 15-fold
dilutions were made at the indicated times. The 0.4-day disaggregation
curve from Fig. 1B (dotted line) is reproduced in B to allow comparison
with A␤-(1– 40) protofibrils.

FIG. 6. Circular dichroism spectra for monomeric and aggregated A␤. A, A␤-(1– 40) (30 M) in three conformational states. Shown
are spectra for stock monomeric A␤-(1– 40) in 5 mM Tris-HCl (pH 8.0)
(solid line) or after the addition of 30% HFIP (dotted line). A␤-(1– 40)
protofibrils were isolated by SEC in the same buffer (dashed line). The
protofibril concentration (in A␤ monomer units) was estimated from
absorbance corrected for light scattering (35) and confirmed by absorbance (⑀276 nm of 1450 cm⫺1 M⫺1) following dissolution by the addition of
HFIP to 30%. B, CD spectra for monomeric A␤-(1– 40) (30 M) in 5 mM
Tris-HCl (solid) and after incubation for 24 h with 2% HFIP. The HFIP
was added either neat (dotted line) or from 4% HFIP in water that had
been aged for 1 month and centrifuged at 18,000 ⫻ g for 10 min (dashed
line). The solid line from A is shown for comparison.
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duced in 2% HFIP ranged from 30 to 80 nm, similar to those
obtained previously for A␤-(1– 40) protofibrils (35), but a second
subpeak with RH ⬎ 300 nm emerged after several days in 2%
HFIP. Analysis of the HFIP-induced A␤ aggregates by SEC
separation in-line with MALS (SEC-MALS) was complicated by
their rapid disaggregation, but measurements were obtained
when the aggregates were stabilized by inclusion of 2% HFIP
during SEC. Zimm plots indicated that the Mw of the HFIPinduced aggregates of radiomethylated A␤ ranged from 18 to
25 ⫻ 103 kDa and that their z-average radius of gyration (Rgz)
ranged from 90 to 110 nm. These values also are comparable
with those we measured previously for radiomethylated A␤-(1–
40) protofibrils (35).
To determine whether the progressive stabilization of HFIPinduced A␤ aggregates that occurred during continued incubation of the aggregation reactions was accompanied by morphological changes, we examined the aggregation reactions by EM
and AFM. EM analysis was conducted following negative staining of samples with uranyl acetate. Control samples of freshly
diluted 2% HFIP showed no features in EM images, but the
addition of BSA to the diluted HFIP resulted in the appearance
of circular objects (Fig. 7A). The number of these objects was
greatly reduced when the 2% HFIP solutions were centrifuged
at 18,000 ⫻ g for 10 min before and after the addition of BSA
(data not shown). These observations implied that BSA had
slightly adsorbed to spherical HFIP aggregates and supported
the evidence from DLS above that HFIP forms a dispersion of
microdroplets in dilute aqueous solution. A solution of A␤-(1–
40) was prepared in freshly diluted 2% HFIP, and aliquots were
removed at several time points, centrifuged at 18,000 ⫻ g for 10
min, and examined by EM. After 1 h of incubation, clustered
globular structures were the predominant negatively stained

FIG. 8. AFM images of HFIP-induced A␤-(1– 40) aggregates also
show changes in morphology with time. Samples were taken at the
indicated times from the same incubated solution of A␤-(1– 40) in 2%
HFIP described in Fig. 7 and diluted 25-fold with 2% HFIP. Aliquots
(100 l) were applied directly to the mica surface. Images are 2.5 ⫻ 2.5
M, and insets are on this same scale.

feature (Fig. 7B). Some individual globular structures also
were observed (Fig. 7B, inset). The diameter of the globules
extended over a range of 20 –200 nm, and punctate deposits
could be seen on several of the larger globules. The globules
presumably represented HFIP microdroplets upon which A␤
had deposited and begun to aggregate. However, based on their
fluorescence with thioflavin T, these A␤ deposits differed from
the BSA-coated microdroplets by remaining soluble after centrifugation at 18,000 ⫻ g. Two days later, the clustered globular structures were incorporated into a mesh or lattice of fiberlike elements (Fig. 7C), and after 9 days, more distinct fibers
were apparent (Fig. 7D). These included long fibers from which
many short fibers branched and, very rarely, structures resem-
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FIG. 7. Electron micrographs of HFIP-induced A␤-(1– 40) aggregates reveal progressive changes in morphology. Bovine serum
albumin (0.25 mg/ml) (A) or SEC-purified monomeric A␤-(1– 40) (40 M) (B–E) were incubated in 5 M thioflavin T, 5 mM Tris-HCl (pH 8.0), and
2% HFIP (undiluted) at room temperature. After 0.1 h, a 10-l sample of the BSA solution was removed, and at the indicated times, aliquots of
the A␤-(1– 40) solution were centrifuged at 18,000 ⫻ g for 10 min and supernatant samples (10 l) were removed. These samples were processed
for negative staining and EM. F, SEC-purified monomeric A␤-(1– 40) (100 M) in 30 mM Tris-Cl (pH 8.0) was incubated with agitation for 22 h. An
aliquot was centrifuged (18,000 ⫻ g for 10 min) and diluted 30-fold, and the protofibrils in the supernatant were elongated by the addition of
monomeric A␤-(1– 40) (30 M) for 15 min. A 10-l sample was removed for negative staining and EM as in A–E. Images and insets are shown
relative to a calibration bar of 200 nm.
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concentrations were matched to the same initial thioflavin T
fluorescence. We concluded that the seeding efficiency of the
HFIP-induced aggregates was much lower than that of protofibrils in aqueous buffers without HFIP.
DISCUSSION

bling initial microdroplets on which fibers had formed (Fig. 7D,
inset). After 23 days (Fig. 7E) the HFIP-induced fibers appeared similar to control fibrils produced by elongation of A␤(1– 40) protofibrils (Fig. 7F), but numerous short branches remained that were not found on the control fibrils.
AFM images supported and extended the features of HFIPinduced A␤ aggregates observed by EM. The same mixture of
clustered globular structures and individual globules was observed 1 h after adding A␤-(1– 40) to dilute HFIP (Fig. 8, A and
inset). The heights of the clustered structures typically ranged
from 10 to 15 nm but in some cases extended to over 50 nm.
After 23 days, fibers with heights of 4 –5 nm had appeared, and
numerous very short rods with heights of 2.5– 4 nm had
emerged that were barely evident in the 1-h sample (Fig. 8B).
These short rods were less clear in the EM images, perhaps
because of differences in retention on the EM grid and AFM
mica surfaces or because they showed little negative staining.
A 9-day image showed a fiber-like structure with several
branching arms (Fig. 8B, inset), consistent with the branched
fibers observed by EM.
HFIP-induced A␤ Aggregates Elongate More Slowly than A␤
Protofibrils—The HFIP-induced A␤ aggregates approached the
stability of A␤-(1– 40) protofibrils after incubation for 10 days
(Fig. 5B) To examine whether stabilization resulted in some
structural convergence of these two species, we determined
their relative rates of elongation in the presence of added
A␤-(1– 40) monomer (Fig. 9). The HFIP-induced A␤ aggregates
were diluted in two steps, first to eliminate less stable aggregates and lower the HFIP concentration and then to introduce
monomer. The fluorescence signal still showed slight disaggregation even with monomer, but the rate of disaggregation was
clearly slower than that observed following a control dilution
into solution that did not contain A␤ monomer (data not
shown). Therefore, the net elongation rate of the HFIP-induced
A␤ aggregates was very small compared with that of A␤-(1– 40)
protofibrils (Fig. 9), with the latter rate being almost 30 times
faster than the former. The difference in elongation rates was
not due to a difference in aggregate sizes or concentrations,
since the RH values were similar (Fig. 9) and the aggregate
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FIG. 9. A␤-(1– 40) aggregates induced by dilute HFIP do not
elongate as efficiently as A␤-(1– 40) protofibrils. A␤-(1– 40) aggregation (50 M) was induced in 2% (v/v) HFIP as in Fig. 4B and incubated
for 3 days to promote stabilization. The solution was centrifuged at
18,000 ⫻ g for 10 min, and the A␤ aggregates in the supernatant were
diluted 5-fold in the same buffer for 1 h and then mixed with an equal
volume of 5 mM Tris-EDTA and 5 M thioflavin T with or without
A␤-(1– 40) monomer (60 M final concentration). Fluorescence traces for
these samples were recorded, and the difference in these traces was
added to the initial fluorescence to give the solid curve labeled HFIP.
Elongation of control protofibrils (diluted to 1 M, which matched the
initial HFIP aggregate fluorescence) with monomer (60 M) was conducted in parallel. RH values for protofibrils and HFIP-induced aggregates prior to elongation were 205 and 196 nm, respectively.

Several examples of polymorphism of soluble A␤-(1– 40) aggregates are highlighted in this report. All of the aggregates
exhibited some of the classic features of amyloid structures,
including the binding of thioflavin T with enhancement of its
fluorescence and a predominance of ␤-structure as measured
by CD. However, they differed in morphology, in the capacity to
seed A␤-(1– 40) monomer deposition, and most strikingly in
stability. Differences in stability arose not only from alternative aggregation conditions but also from progressive changes
in the aggregates once they were formed. Progressive changes
in the morphology of small A␤ aggregates (59) and A␤ fibrils
(60) have been observed previously, but the stability of A␤
aggregates has received much less attention. Virtually the only
quantitative estimate of an in vitro disaggregation rate for
soluble A␤ aggregates involved A␤-(1– 40) protofibrils tracelabeled with [125I]A␤-(1– 40). The dialyzed protofibrils released
only about 30% of their radioactivity, mostly over the first 2
days of dialysis (58). This observation is quite compatible with
the extent of disaggregation of A␤-(1– 40) protofibrils that we
observed in Fig. 1B.
The Dock and Lock Model of A␤ Fibril Elongation—Two
additional reports have focused on the dissociation of A␤ after
fresh deposition of A␤ monomer on a solid phase A␤ fibril
template. In an elegant study by Maggio and co-workers (61),
radioiodinated A␤-(1– 40) monomer was deposited onto immobilized synthetic A␤-(1– 40) fibrils for varying periods of time,
and release of 125I-labeled monomers from the washed fibrils
was then monitored. The dissociation kinetics expected in this
experiment depend on the amount of radiolabeled monomer
deposited. If deposition occurred only at a uniform population
of growth points (e.g. fibril ends), deposited A␤ would dissociate
with simple first order kinetics when the number of ends exceeded deposited A␤ and with zero-order kinetics when the
number of ends was much smaller than deposited A␤. Dissociation would follow an exponential time course in the first case
and a linear time course in the second, and this linear rate
would be the same regardless of the amount of deposited A␤.
The data revealed a more complicated process, with a rapid
dissociation phase followed by slower phase(s) indicating that
the growth points are not homogeneous. Furthermore, the percentage of deposited monomer that rapidly dissociated was
found to depend on the length of time the monomer was in
contact with the growing fibril. More than 80% of the radiolabel
dissociated within 2 h after deposition times of 30 min or less,
whereas less than 30% dissociated within 3 days after 12 h of
deposition. The authors proposed a “dock and lock” model in
which A␤ monomer deposits (docks) onto the growing fibril and
then slowly converts (locks) to a conformation that dissociates
from fibril ends much more slowly. These fast and slow components were resolved by a double-exponential dissociation
equation, but such an analysis should be applied with caution.
If much of the dissociation actually involved a constant linear
dissociation rate as noted above, a double exponential analysis
would appear to show an increase in the slow component at
longer deposition times when more monomer was deposited.
This concern was addressed in the second report, where fibrillar A␤-(1– 40) was covalently linked to Biacore biosensor chips
and the deposition and subsequent dissociation of monomeric
A␤-(1– 40) was monitored by surface plasmon resonance (62,
63). Dissociation was again characterized by fast and slow
phases, but in Ref. 62, the total deposited monomer was held
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structures were smaller and more uniform than those initially
formed in dilute HFIP. Previously reported biophysical analyses of aqueous HFIP solutions also support a microdroplet
structure. NMR and small angle neutron scattering data have
indicated microheterogeneities that are maximized at HFIP
concentrations of about 35% (v/v), with clusters involving hydrophobic CF3 groups aggregated in an inside core and hydrophilic OH groups forming hydrogen bonds with surrounding
water molecules (68). Below these concentrations, mass spectrometry revealed hydrated HFIP oligomers of stoichiometry
(HFIP)m(H2O)n. At 2– 4% HFIP (v/v), oligomers with m ⫽ 2– 4
and n ⫽ 5–20 were detected, but larger oligomers were not
explored because of the limited mass number range employed
(68).
The process by which the initial A␤ aggregates formed on
HFIP microdroplet clusters convert to fibers is unclear. Because of the initial instability of these HFIP-induced aggregates, the growth of fibers may reflect monomer dissociation
from the globular clusters and redeposition on more stable
nascent fibers. However, the rare cases of relatively well
formed fibers on spherical structures that resemble microdroplets (Fig. 7D, inset) suggest that some reorganization of the
initial ␤-structured aggregates can occur directly on the microdroplet surface.
Despite the differences between A␤ protofibrils and HFIPinduced aggregates, they both showed progressive stabilization
after initial aggregate formation. After several days of stabilization, the HFIP-induced aggregates formed fibers that had
some resemblance to elongated protofibrils (Fig. 7). However,
these aggregates still seeded monomer elongation with very
different efficiencies (Fig. 9). Further studies are required to
determine the molecular interactions in these aggregates, but
models of amyloid fibrils suggest ways in which differences
could arise. In the structural model for A␤-(1– 40) based on
solid-state NMR data, a cross-␤ unit is composed of two
␤-strand segments involving residues 12–24 and 30 – 40 separated by a segment with a bend angle of 180°, allowing interpeptide hydrogen bonding and separate parallel ␤-sheet formation from both ␤-strands (24). In contrast, low angle x-ray
diffraction analysis of A␤-(11–25) fibrils indicated an antiparallel alignment of fully extended ␤-strands (69). In these fibrils,
the ␤-sheets appeared to stack by slipping relative to each
other by the length of two amino acid units (69), and the
registry of the hydrogen bonding appeared to vary with pH
(24). It is possible then that A␤-(1– 40) protofibrils and HFIPinduced aggregates differ by their ␤-strand alignments or the
registry of their ␤-sheets or hydrogen bonding, and solid state
NMR measurements will be required to resolve this issue.
It will be of interest to determine whether agents or conditions that favor rapid interfacial formation of unstable A␤
aggregates occur in vivo. Analogs of biological membranes,
namely GM1 ganglioside micelles and artificial lipid rafts that
contain GM1 (40), as well as lipoprotein particles (70) have been
reported to bind A␤ peptides in a saturable manner and to
convert the peptide conformations to ␤-structures in the complexes. The stability of these aggregates has not been investigated. A recent study also has found that inhaled anesthetics
promote A␤ aggregation (30). The haloalkane halothane and the
haloether isoflurane, like HFIP, are highly fluorinated, and both
increased the rates of A␤ aggregation as measured by thioflavin
T fluorescence. Furthermore, an EM image of the A␤ aggregates
induced by halothane at concentrations achieved in routine clinical anesthesia (⬍1 mM) was strikingly similar to those in Fig. 7,
C and D, here. The authors suggested that cytotoxicity induced
by these aggregates may contribute to persistent postoperative
cognitive problems that occur in the elderly.
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constant by varying the free monomer concentration over different exposure times. Progressive stabilization was apparent,
as the amplitude of the fast dissociation phase became smaller
after longer exposure times, and the dock and lock model was
invoked to explain this phenomenon (62).
While the dock and lock model can explain some of the protofibril stabilization observed in Fig. 1, it may be too limiting. Over
50% of the protofibril fluorescence is lost following the initial
dilution in Fig. 1A, despite the fact that the size of the protofibrils
obtained with our aggregation and SEC isolation procedures
exceeds 1500 monomer units (see Ref. 35). Furthermore, the
isolated A␤ protofibrils underwent progressive stabilization even
in the absence of monomer. These observations suggest that
protofibrils become more stable not just at their ends but through
an intrinsic secondary or tertiary structural change extending
over a substantial portion of the protofibril (e.g. tightening of the
amyloid filament ␤-sheet structure).
A Critical Monomer Concentration for A␤ Aggregation—The
progressive stabilization of A␤ protofibrils that we observed in
Fig. 1 raises concerns about estimates by some groups of a
critical monomer concentration, MC, required for in vitro A␤
aggregation. Estimates of MC for A␤-(1– 40), based on the soluble A␤ remaining after 3–5 days of incubation in buffered
saline at pH 7.4, ranged from 6 to 35 M (64) (see Ref. 65). The
equilibrium assumed in MC determinations is very difficult to
achieve if the rate constants for monomer addition to protofibril
ends (kon) and monomer dissociation from these ends (koff) are
continually decreasing. When aggregated A␤ is at equilibrium
with A␤ monomer, MC ⫽ koff/kon (66, 67). Aggregate growth by
monomer deposition occurs when monomer concentrations are
greater than MC, and MC estimates by this criterion are considerably smaller than those obtained from solubility determinations. Elongation of fibrillar A␤-(1– 40) on biosensor surfaces
occurred at A␤-(1– 40) monomer concentrations as low as 0.2
M, and estimates of MC were about 0.02 M (63). Solution
measurements of protofibril growth by elongation with thioflavin T (as in Fig. 9) have less sensitivity than the biosensor, but
we have detected monomer deposition and net growth at A␤(1– 40) monomer concentrations of 0.5 M.3 We suggest that the
difference between solubility and kinetic estimates of MC arises
because these structures not only become more resistant to
disaggregation with time but also become more resistant to
elongation.
Dilute HFIP Appears to Promote Interfacial A␤ Aggregation—The rapid formation of unstable A␤ aggregates in 1–2%
HFIP is a striking illustration of A␤ aggregate polymorphism.
All of the features of dilute aqueous solutions of HFIP that
promote the formation of these aggregates are not yet defined,
but we propose that they include A␤ interactions at interfaces
generated by the formation of HFIP microdroplets in the aqueous solvent. This proposal is consistent with our observation of
BSA-coated spherical aggregates of HFIP in the EM images in
Fig. 7A and with the demonstration in Fig. 4C that centrifugation of the 2– 4% HFIP stocks removed light scattering particles
and decreased the rate and extent of A␤ aggregation. A␤ is an
amphipathic molecule, and we have recently reported a dramatic acceleration of A␤ aggregation at the interface of a macroscopic two-phase system formed by buffer and chloroform
(41). These two-phase A␤ aggregates, like those induced in
dilute HFIP, contained primarily ␤-structure according to their
CD spectra and rapidly disaggregated upon dilution. The twophase A␤ aggregates also formed globular species that progressed to fibers based on AFM images, but these globular
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